Clearmind Medicine (CMND) Competitors $1.02 +0.01 (+0.99%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CMND vs. ALLR, CMMB, SLGL, EQ, UBX, CING, EDSA, NAII, LPCN, and LPTXShould you be buying Clearmind Medicine stock or one of its competitors? The main competitors of Clearmind Medicine include Allarity Therapeutics (ALLR), Chemomab Therapeutics (CMMB), Sol-Gel Technologies (SLGL), Equillium (EQ), Unity Biotechnology (UBX), Cingulate (CING), Edesa Biotech (EDSA), Natural Alternatives International (NAII), Lipocine (LPCN), and Leap Therapeutics (LPTX). These companies are all part of the "pharmaceutical products" industry. Clearmind Medicine vs. Allarity Therapeutics Chemomab Therapeutics Sol-Gel Technologies Equillium Unity Biotechnology Cingulate Edesa Biotech Natural Alternatives International Lipocine Leap Therapeutics Allarity Therapeutics (NASDAQ:ALLR) and Clearmind Medicine (NASDAQ:CMND) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability, media sentiment and community ranking. Does the media prefer ALLR or CMND? In the previous week, Clearmind Medicine had 6 more articles in the media than Allarity Therapeutics. MarketBeat recorded 9 mentions for Clearmind Medicine and 3 mentions for Allarity Therapeutics. Allarity Therapeutics' average media sentiment score of 0.79 beat Clearmind Medicine's score of 0.21 indicating that Allarity Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Allarity Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Clearmind Medicine 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings & valuation, ALLR or CMND? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAllarity TherapeuticsN/AN/A-$11.90MN/AN/AClearmind MedicineN/AN/A-$5.26M-$1.22-0.83 Is ALLR or CMND more profitable? Clearmind Medicine's return on equity of -129.21% beat Allarity Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Allarity TherapeuticsN/A -369.67% -100.06% Clearmind Medicine N/A -129.21%-61.15% Which has more volatility and risk, ALLR or CMND? Allarity Therapeutics has a beta of -0.06, meaning that its share price is 106% less volatile than the S&P 500. Comparatively, Clearmind Medicine has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500. Does the MarketBeat Community believe in ALLR or CMND? Allarity Therapeutics received 1 more outperform votes than Clearmind Medicine when rated by MarketBeat users. CompanyUnderperformOutperformAllarity TherapeuticsOutperform Votes150.00% Underperform Votes150.00% Clearmind MedicineN/AN/A Do institutionals and insiders hold more shares of ALLR or CMND? 11.5% of Allarity Therapeutics shares are held by institutional investors. Comparatively, 96.1% of Clearmind Medicine shares are held by institutional investors. 0.1% of Allarity Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryClearmind Medicine beats Allarity Therapeutics on 6 of the 9 factors compared between the two stocks. Get Clearmind Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for CMND and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CMND vs. The Competition Export to ExcelMetricClearmind MedicinePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.33M$6.72B$5.49B$7.94BDividend YieldN/A3.05%5.11%4.23%P/E Ratio-0.547.3722.5818.55Price / SalesN/A242.94397.25103.00Price / CashN/A65.8538.1834.62Price / Book1.396.486.704.26Net Income-$5.26M$143.68M$3.23B$248.39M7 Day Performance3.57%1.79%1.26%1.27%1 Month Performance-1.46%6.68%3.75%3.85%1 Year Performance-13.98%-2.73%15.78%5.23% Clearmind Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CMNDClearmind Medicine1.0732 of 5 stars$1.02+1.0%N/A-15.0%$4.35MN/A-0.54N/AShort Interest ↓Gap DownALLRAllarity Therapeutics0.2983 of 5 stars$0.99-3.8%N/A-96.9%$16.86MN/A0.0010CMMBChemomab Therapeutics3.579 of 5 stars$1.17+0.9%$9.00+669.2%+92.9%$16.80MN/A-1.1720Upcoming EarningsShort Interest ↓News CoverageSLGLSol-Gel Technologies2.3707 of 5 stars$0.60+2.1%$5.00+737.5%+6.7%$16.63M$11.71M-1.7650News CoverageGap DownEQEquillium2.8051 of 5 stars$0.47+2.2%$3.00+545.2%-71.8%$16.61M$41.10M-3.3240Upcoming EarningsShort Interest ↓Positive NewsUBXUnity Biotechnology4.1199 of 5 stars$0.98+4.5%$5.33+443.1%-26.6%$16.56M$240,000.00-0.7560Analyst RevisionNews CoverageCINGCingulate2.5198 of 5 stars$4.16+2.2%$30.67+637.2%+350.8%$16.40MN/A-0.2820Short Interest ↑News CoverageEDSAEdesa Biotech3.103 of 5 stars$2.33-2.1%$21.00+801.3%-47.6%$16.29MN/A-1.2520Short Interest ↓NAIINatural Alternatives International0.9823 of 5 stars$2.62+0.4%N/A-52.0%$16.24M$121.85M-2.03290LPCNLipocine2.495 of 5 stars$3.01flat$10.00+232.2%-28.4%$16.10M$11.20M-3.9610Upcoming EarningsAnalyst ForecastNews CoverageLPTXLeap Therapeutics2.4532 of 5 stars$0.39+7.3%$4.92+1,173.7%-86.5%$15.93MN/A-0.2040Gap Down Related Companies and Tools Related Companies ALLR Competitors CMMB Competitors SLGL Competitors EQ Competitors UBX Competitors CING Competitors EDSA Competitors NAII Competitors LPCN Competitors LPTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CMND) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearmind Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearmind Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
